http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04210975-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
filingDate 1991-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_714b186cda5dacd54c823432a0beaf8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9ec7550fb1f381abbb8733bbd993edd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2a51f7de2436b36682e2b63299c2427
publicationDate 1992-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04210975-A
titleOfInvention Oxazole compound
abstract PURPOSE: To obtain a new oxazole compound having bone amount reduction- suppressing action and bone amount-increasing action as well as low toxicity. n CONSTITUTION: The objective oxazole compound expressed by formula I [A is -CH 2 OR 2 (R 2 is H, hydrocarbon residue, heterocyclic ring or acyl) or aldehyde; B is phenyl; R 2 is H or alkyl; n is integer of 0-6, provided that when n=2, R 1 is alkyl] or salt thereof, e.g. 4-(3,5-ditrifluoromethylphenyl)-2-oxazole propionic acid ethyl ester. A compound expressed by the formula I-1 wherein A is COOR 6 (R 6 is alkyl or aralkyl) in the compound expressed by formula I is obtained by reacting a compound expressed by formula II or salt thereof with a dicarboxylic acid monoamide expressed by formula III. n COPYRIGHT: (C)1992,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9420476-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004250401-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020007347-A
priorityDate 1990-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53865941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234844600

Total number of triples: 38.